Hypersensitivity syndrome reaction (HSR) de scribes a drug induced sym
ptom complex consisting of fever, rash, and internal organ involvement
. Although these reactions are rare, they are very important because o
f their severity and unpredictability. The metabolic conversion of dru
gs to chemically reactive products is now established as a prerequisit
e for many idiosyncratic drug reactions. In the setting of HSR, an imb
alance in the rates of formation of reactive metabolites and of enzyma
tic detoxification can lead to accumulation of these byproducts. React
ive metabolites could act as haptens eliciting an immune response, cov
alently bind target proteins causing cell death, or interact with nucl
eic acids leading to mutations. The lymphocyte toxicity assay (LTA) pr
ovides an in vitro assessment of host susceptibility to reactive metab
olites of a given drug. It has validated the clinical finding of incre
ased risk of HSR in first degree relatives of patients. It is hoped th
at the LTA will be used to predict host susceptibility before drug exp
osure. Ultimately it is hoped that the genetic defects that lead to dr
ug reactions will be identified. This would improve drug develop ment
safety and allow primacy prevention of serious reactions. Copyright (C
) 1996 by W.B. Saunders Company.